ViewBag.Title

Quality Payment Program Measures Data

Back to Merit-based Incentive Payment System

         

Measure ID NQF ID National Quality Strategy Domain Title High Priority Measure Type Submission Methods Speciality Measure Sets
ASPS5 Patient Safety Breast Reconstruction: Return to OR Outcome Registry Details
ASPS7 Patient Safety Rate of Blood Transfusion for Patients Undergoing Autologous Breast Reconstruction Outcome Registry Details
ASPS8 Communication and Care Coordination Coordination of Care for Patients Undergoing Breast Reconstruction Process Registry Details
ASPS9 Efficiency and Cost Reduction Length of Stay Following Autologous Breast Reconstruction Outcome Registry Details
CAP10 Effective Clinical Care Blood Laboratory Samples for Potassium Determination with Hemolysis Drawn in ED Intermediate Outcome Registry Details
CAP11 Communication and Care Coordination Accurate Human Epidermal Growth Factor Receptor 2 (HER2) Tumor Evaluation and Repeat Evaluation in Patients with Breast Carcinoma Process Registry Details
CAP12 Communication and Care Coordination Accurate Human Epidermal Growth Factor Receptor 2 (HER2) Tumor Evaluation and Repeat Evaluation in Patients with Gastroesophageal Adenocarcinoma Process Registry Details
CAP13 Communication and Care Coordination Anaplastic Lymphoma Kinase (ALK) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer Process Registry Details
CAP15 Communication and Care Coordination BRAF Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Metastatic Colorectal Adenocarcinoma Process Registry Details
CAP16 Communication and Care Coordination Epidermal Growth Factor Receptor (EGFR) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer Process Registry Details
CAP17 Communication and Care Coordination FMS-like Tyrosine 3-Internal Tandem Duplication (FLT3-ITD) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Acute Myeloid Leukemia Process Registry Details
CAP18 Communication and Care Coordination Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Primary or Metastatic Colorectal Carcinoma Process Registry Details
CAP19 Communication and Care Coordination ROS 1 Biomarker Testing to Inform Clinical Management and Treatment Decisions in Patients with Non-small Cell Lung Cancer Process Registry Details
CAP20 Communication and Care Coordination High Risk HPV Testing and p16 Scoring in Surgical Specimens for Patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC) Process Registry Details
CAP21 Communication and Care Coordination High Risk HPV Testing in Cytopathology Specimens for Patients with Oropharyngeal Squamous Cell Carcinoma (OPSCC) Process Registry Details
CAP22 Communication and Care Coordination Turnaround Time (TAT) - Biopsies Process Registry Details
CAP23 Communication and Care Coordination Cancer Protocol Elements and Turnaround Time for Carcinoma and Carcinosarcoma of the Endometrium Process Registry Details
CAP24 Communication and Care Coordination Cancer Protocol Elements and Turnaround Time for Carcinoma of the Intrahepatic Bile Ducts Process Registry Details
CAP25 Communication and Care Coordination Cancer Protocol Elements and Turnaround Time for Carcinoma of the Pancreas Process Registry Details
CAP26 Communication and Care Coordination Cancer Protocol Elements and Turnaround Time for Hepatocellular Carcinoma Process Registry Details

Page 19 of 32
Back to Merit-based Incentive Payment System